ArticleAnnals of translational medicine2019

Serial bipolar androgen therapy (sBAT) using cyclic supraphysiologic testosterone (STP) to treat metastatic castration-resistant prostate cancer (mCRPC).

John T Isaacs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.